While it is possible that Novo Nordisk may sue Hims based on alleged patent infringement after the April 22 FDA enforcement deadline for 503A compounding facilities, this would be a risky decision that could backfire on Novo
These included ad libitum energy intake, ratings of appetite, thirst, nausea, well-being, control of eating, food preference, resting metabolic rate, body weight, and body composition
Still, we can speculate what might be happening based on our understanding of how the body responds to weight loss, including altered metabolism, reduced blood flow to extremities, decreased food-induced heat production, and loss of insulating body fat
Are there any side effects of GLP-1 pill